Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology is presented at the UK Biological Knee Society’s Annual Meeting 2022 (Peckforton Castle, Cheshire, March 15-16),  as a part of the scientific program. The presentation is held by Mr Paul Jermin from Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, United Kingdom, and focuses on surgical technology and clinical results from the use of the Episealer® Knee implant.

“As the orthopaedic community once again gathers for important physical meetings, we are pleased to see that the Episealer® is on the agenda. The UK market will grow in importance for us, and this is a great forum for our technology”, says Pål Ryfors, CEO, Episurf Medical.